Being overweight or obese does not lead to improved survival among patients with type 2 diabetes, according to data from the Nurses Health Study and Health Professionals Follow-up Study.
Researchers with the Harvard School of Public Health in Boston said findings of their large-scale study refute previous studies that have suggested that, for people with diabetes, being overweight or obese could lead to lower mortality compared with normal-weight people.
These data dispel the notion that being overweight or obese confers survival advantage among diabetic patients, Frank Hu, professor of nutrition and epidemiology at HSPH and senior author of the study, said in a news release. Clearly, weight management is an important therapeutic strategy for overweight or obese individuals with type 2 diabetes.
As published in the Jan. 16 issue of the New England Journal of Medicine, the researchers analyzed data from 8,970 women in the Brigham and Womens Hospital-based Nurses Health Study and 2,457 men in the Health Professionals Follow-up Study with type 2 diabetes.
They calculated participants body-mass index shortly before the diagnosis of diabetes and excluded participants who reported a history of diabetes at baseline or cardiovascular disease or cancer before they were diagnosed with diabetes; underweight participants also were excluded.
Participants were followed for a maximum of 36 years (NHS) and 26 years (HPFS). A total of 3,083 deaths were recorded.
The results showed a positive association between BMI at the time of diabetes diagnosis and risk of death from all causes. The lowest risk of death was observed among people of normal weight. Lower mortality was not observed among overweight or obese participants, meaning the findings showed no benefit from being overweight or obese.
In addition, there was a dose-response relationship between BMI and mortality among people who had never smoked, such that a higher BMI just prior to diabetes diagnosis was associated with a higher risk of death. This trend was less pronounced among smokers because smokers tend to be leaner than nonsmokers but have increased risk of death, the researchers noted.
The results contradict some previous studies that had shown a lower risk of death for patients with chronic illnesses, such as type 2 diabetes, and excess adiposity. Limitations in those studies include small sample sizes, measurement of BMI years after diabetes diagnosis and failure to properly assess biases from smoking and undiagnosed chronic diseases, which often lead to weight loss.
In most studies of BMI and mortality, normal weight reference groups are comprised of not only tose who are lean and healthy, but also smokers as well as people with existing or undiagnosed illnesses, Deirdre Tobias, ScD, lead author of the paper and a research fellow in the Department of Nutrition at HSPH, said in the news release. “This can skew the relationship between weight and mortality to make the normal-weight group seem worse off than the overweight and obese groups. As a result, people with higher BMIs might have artificially improved survival rates.
After carefully controlling for many of these factors in our analysis, we observed that excess weight in those with diabetes was not advantageous for survival. These findings underscore the importance of addressing methodological biases in the analysis of BMI and mortality.